The central risk is validation, not financing.
QCi has the balance sheet and assets to try, but it still must prove that
Dirac-3S,
NeuraWave, secure links, and
foundry-packaging services convert from
backlog and pilots into repeat revenue with better utilization and
gross margin. If that proof lags, valuation can compress quickly toward a low-volume specialty hardware profile.